Edwards Lifesciences ROE 2010-2024 | EW

Current and historical return on equity (ROE) values for Edwards Lifesciences (EW) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Edwards Lifesciences ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-03-31 $1.41B $7.19B 20.89%
2023-12-31 $1.40B $6.72B 21.62%
2023-09-30 $1.43B $6.73B 22.86%
2023-06-30 $1.39B $6.45B 22.66%
2023-03-31 $1.49B $6.06B 24.78%
2022-12-31 $1.52B $5.81B 25.56%
2022-09-30 $1.46B $6.22B 24.48%
2022-06-30 $1.46B $5.94B 25.12%
2022-03-31 $1.54B $5.85B 27.54%
2021-12-31 $1.50B $5.84B 28.40%
2021-09-30 $1.48B $5.54B 29.70%
2021-06-30 $1.46B $5.13B 31.50%
2021-03-31 $0.85B $4.66B 19.70%
2020-12-31 $0.82B $4.57B 19.95%
2020-09-30 $0.79B $4.21B 19.73%
2020-06-30 $0.74B $3.84B 18.95%
2020-03-31 $1.11B $3.90B 28.85%
2019-12-31 $1.05B $4.15B 28.09%
2019-09-30 $0.77B $3.82B 22.27%
2019-06-30 $0.73B $3.50B 21.56%
2019-03-31 $0.77B $3.45B 23.37%
2018-12-31 $0.72B $3.14B 22.40%
2018-09-30 $0.71B $3.36B 22.41%
2018-06-30 $0.66B $3.16B 20.98%
2018-03-31 $0.56B $3.25B 18.20%
2017-12-31 $0.58B $2.96B 19.76%
2017-09-30 $0.75B $3.16B 25.99%
2017-06-30 $0.72B $2.94B 26.05%
2017-03-31 $0.66B $2.74B 24.97%
2016-12-31 $0.57B $2.62B 22.62%
2016-09-30 $0.55B $2.69B 22.16%
2016-06-30 $0.53B $2.47B 21.83%
2016-03-31 $0.52B $2.30B 21.66%
2015-12-31 $0.50B $2.50B 21.00%
2015-09-30 $0.46B $2.42B 20.32%
2015-06-30 $0.44B $2.29B 20.14%
2015-03-31 $0.87B $2.21B 41.80%
2014-12-31 $0.81B $2.19B 43.31%
2014-09-30 $0.78B $2.04B 45.42%
2014-06-30 $0.76B $1.92B 48.68%
2014-03-31 $0.31B $1.34B 20.67%
2013-12-31 $0.39B $1.54B 25.29%
2013-09-30 $0.40B $1.44B 26.48%
2013-06-30 $0.40B $1.58B 25.54%
2013-03-31 $0.37B $1.59B 24.50%
2012-12-31 $0.29B $1.48B 19.93%
2012-09-30 $0.27B $1.54B 18.60%
2012-06-30 $0.25B $1.44B 17.98%
2012-03-31 $0.24B $1.39B 17.41%
2011-12-31 $0.24B $1.34B 17.44%
2011-09-30 $0.24B $1.36B 17.68%
2011-06-30 $0.24B $1.39B 17.79%
2011-03-31 $0.24B $1.36B 18.73%
2010-12-31 $0.22B $1.31B 18.20%
2010-09-30 $0.20B $1.23B 17.33%
2010-06-30 $0.23B $1.12B 20.19%
2010-03-31 $0.22B $1.15B 19.80%
2009-12-31 $0.23B $1.16B 22.03%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $52.601B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $218.361B 26.46
Intuitive Surgical (ISRG) United States $151.024B 90.98
DexCom (DXCM) United States $46.111B 69.85
Alcon (ALC) Switzerland $44.714B 32.04
IDEXX Laboratories (IDXX) United States $41.624B 48.79
IQVIA Holdings (IQV) United States $38.763B 22.49
STERIS (STE) Ireland $21.579B 25.21
SONOVA HOLDING (SONVY) Switzerland $18.556B 0.00
Waters (WAT) United States $17.496B 25.71
Hologic (HOLX) United States $16.754B 18.74
Fresenius Medical Care AG KGaA (FMS) Germany $12.100B 14.12
Sysmex ADR (SSMXY) Japan $9.900B 31.05
Teleflex (TFX) United States $9.811B 15.27
Globus Medical (GMED) United States $8.882B 26.04
Penumbra (PEN) United States $7.279B 82.72
Masimo (MASI) United States $7.203B 41.50
Glaukos (GKOS) United States $5.671B 0.00
TransMedics (TMDX) United States $4.677B 443.78
Integer Holdings (ITGR) United States $3.897B 23.54
PROCEPT BioRobotics (PRCT) United States $3.248B 0.00
Tandem Diabetes Care (TNDM) United States $2.928B 0.00
LivaNova (LIVN) United Kingdom $2.853B 16.94
Inari Medical (NARI) United States $2.634B 0.00
Integra LifeSciences Holdings (IART) United States $2.305B 10.05
RxSight (RXST) United States $2.141B 0.00
Veracyte (VCYT) United States $1.603B 0.00
Alphatec Holdings (ATEC) United States $1.491B 0.00
Artivion (AORT) United States $0.964B 92.48
AVANOS MEDICAL, INC (AVNS) United States $0.883B 17.18
OPKO Health (OPK) United States $0.871B 0.00
Silk Road Medical (SILK) United States $0.844B 0.00
OrthoPediatrics (KIDS) United States $0.698B 0.00
Pulse Biosciences (PLSE) United States $0.664B 0.00
IRadimed (IRMD) United States $0.548B 30.67
SiBone (SIBN) United States $0.522B 0.00
Paragon 28 (FNA) United States $0.510B 0.00
Mesa Laboratories (MLAB) United States $0.494B 14.66
Pacific Biosciences Of California (PACB) United States $0.479B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.465B 0.00
Treace Medical Concepts (TMCI) United States $0.375B 0.00
AxoGen (AXGN) United States $0.334B 0.00
Nevro (NVRO) United States $0.332B 0.00
Sight Sciences (SGHT) United States $0.326B 0.00
Tactile Systems Technology (TCMD) United States $0.280B 9.58
Semler Scientific (SMLR) United States $0.271B 13.73
AngioDynamics (ANGO) United States $0.246B 0.00
CVRx (CVRX) United States $0.220B 0.00
Delcath Systems (DCTH) United States $0.212B 0.00
908 Devices (MASS) United States $0.200B 0.00
EDAP TMS S.A (EDAP) France $0.200B 0.00
NeuroPace (NPCE) United States $0.186B 0.00
Inogen (INGN) United States $0.172B 0.00
Accuray (ARAY) United States $0.172B 0.00
Alpha Tau Medical (DRTS) Israel $0.160B 0.00
Atossa Genetics (ATOS) United States $0.151B 0.00
ClearPoint Neuro (CLPT) United States $0.148B 0.00
Yubo Biotech (YBGJ) China $0.123B 0.00
Spectral Diagnostics (EDTXF) Canada $0.101B 0.00
KORU Medical Systems (KRMD) United States $0.098B 0.00
Sensus Healthcare (SRTS) United States $0.087B 18.28
Monogram Orthopaedics (MGRM) United States $0.065B 0.00
EnVVeno Medical (NVNO) United States $0.064B 0.00
InspireMD (NSPR) Israel $0.063B 0.00
Hyperfine (HYPR) United States $0.063B 0.00
Neuronetics (STIM) United States $0.061B 0.00
SEP Acquisition (SEPA) United States $0.055B 0.00
LENSAR (LNSR) United States $0.053B 0.00
Envoy Medical (COCH) United States $0.051B 0.00
T2 Biosystems (TTOO) United States $0.045B 0.00
Vicarious Surgical (RBOT) United States $0.040B 0.00
Lucid Diagnostics (LUCD) United States $0.039B 0.00
ReWalk Robotics (LFWD) Israel $0.039B 0.00
Precision Optics (POCI) United States $0.037B 0.00
DarioHealth (DRIO) United States $0.035B 0.00
Rapid Micro Biosystems (RPID) United States $0.033B 0.00
Accelerate Diagnostics (AXDX) United States $0.030B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Autonomix Medical (AMIX) United States $0.028B 0.00
Pixie Dust Technologies (PXDT) Japan $0.026B 0.00
Aspira Women's Health (AWH) United States $0.025B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.024B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Venus Concept (VERO) Canada $0.006B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
ENDRA Life Sciences (NDRA) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00